Trial Details
Tracking Renal Tumors After Cryoablation Evaluation (TRACE) Registry
NCT01117779
TERMINATED
DESCRIPTION
TRACE is an observational, open-label, single-arm, multi-center registry of subjects who have undergone renal lesion cryoablation per their physician's standard of care. Patients 18 years of age or older who have been determined to be an appropriate candidate for cryoablation will be offered enrollment into the registry. Subjects will be observed for five years from the date of their cryoablation procedure.
CONDITIONS
Kidney Neoplasms
ELIGIBILITY CRITERIA
- Suggested
- Inclusion Criteria
- :
- Patient is at least 18 years of age.
- Patient has a renal lesion suspicious for malignancy.
- Patient is to undergo renal lesion cryoablation via a Galil Medical cryoablation system using Galil Medical needles for treatment of primary or recurrent disease.
- Patient is to be available for long-term follow-up per the enrolling physician's standard care practices.
- Patient has provided written informed consent.
Suggested
- Exclusion Criteria
- :
- Patient is either currently using or has used within the last 30 days an investigational product of any type.
- Patient has metastatic disease to or from the kidney.
- Patient has had previous therapy on the index lesion (e.g. radiofrequency, cryoablation, partial nephrectomy).
